Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study

BACKGROUND: Conventional glucocorticoid treatment has a significant impact on liver in patients with adrenal insufficiency. Dual-release hydrocortisone (DR-HC) provides physiological cortisol exposure, leading to an improvement in anthropometric and metabolic parameters. We aimed to evaluate the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnotta, Valentina, Mineo, Mariagrazia Irene, Radellini, Stefano, Pizzolanti, Giuseppe, Giordano, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713956/
https://www.ncbi.nlm.nih.gov/pubmed/31489172
http://dx.doi.org/10.1177/2042018819871169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713956/
https://www.ncbi.nlm.nih.gov/pubmed/31489172
http://dx.doi.org/10.1177/2042018819871169

Ejemplares similares